These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 12940804)
1. Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Di Monda V; Nicolodi M; Aloisio A; Del Bianco P; Fonzari M; Grazioli I; Uslenghi C; Vecchiet L; Sicuteri F Headache; 2003 Sep; 43(8):835-44. PubMed ID: 12940804 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Sandrini G; Cerbo R; Del Bene E; Ferrari A; Genco S; Grazioli I; Martelletti P; Nappi G; Pinessi L; Sarchielli P; Tamburro P; Uslenghi C; Zanchin G Int J Clin Pract; 2007 Aug; 61(8):1256-69. PubMed ID: 17627707 [TBL] [Abstract][Full Text] [Related]
3. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache. Hoy SM; Scott LJ CNS Drugs; 2011 Apr; 25(4):343-58. PubMed ID: 21425885 [TBL] [Abstract][Full Text] [Related]
4. Effect of overuse of the antimigraine combination of indomethacin, prochlorperazine and caffeine (IPC) on the disposition of its components in chronic headache patients. Ferrari A; Savino G; Gallesi D; Pinetti D; Bertolini A; Sances G; Coccia CP; Pasciullo G; Leone S; Loi M; Sternieri E Pharmacol Res; 2006 Aug; 54(2):142-9. PubMed ID: 16697657 [TBL] [Abstract][Full Text] [Related]
6. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
7. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
9. The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. Ghelardini C; Galeotti N; Vivoli E; Grazioli I; Uslenghi C J Headache Pain; 2009 Dec; 10(6):435-40. PubMed ID: 19756945 [TBL] [Abstract][Full Text] [Related]
10. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study. Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341 [TBL] [Abstract][Full Text] [Related]
11. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults. Law S; Derry S; Moore RA Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438 [TBL] [Abstract][Full Text] [Related]
12. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634 [TBL] [Abstract][Full Text] [Related]
13. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies. Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417 [TBL] [Abstract][Full Text] [Related]
14. Sumatriptan plus naproxen for acute migraine attacks in adults. Law S; Derry S; Moore RA Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431 [TBL] [Abstract][Full Text] [Related]
15. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Goldstein J; Silberstein SD; Saper JR; Elkind AH; Smith TR; Gallagher RM; Battikha JP; Hoffman H; Baggish J Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110 [TBL] [Abstract][Full Text] [Related]
16. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
17. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Mathew NT Headache; 2003; 43(10):1075-9. PubMed ID: 14629242 [TBL] [Abstract][Full Text] [Related]
18. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Derry CJ; Derry S; Moore RA Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849 [TBL] [Abstract][Full Text] [Related]
19. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. Ghelardini C; Galeotti N; Grazioli I; Uslenghi C J Pain; 2004 Oct; 5(8):413-9. PubMed ID: 15501422 [TBL] [Abstract][Full Text] [Related]
20. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Cady RK; Sheftell F; Lipton RB; O'Quinn S; Jones M; Putnam DG; Crisp A; Metz A; McNeal S Clin Ther; 2000 Sep; 22(9):1035-48. PubMed ID: 11048903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]